GHSI — Guardion Health Sciences Balance Sheet
0.000.00%
- $4.22m
- -$10.60m
- $12.25m
- 36
- 70
- 56
- 54
Annual balance sheet for Guardion Health Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 11.1 | 8.52 | 9.09 | 15.9 | 6.36 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.078 | 0.011 | 1.41 | 1.92 | 2.27 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 11.9 | 9.09 | 12.1 | 21.6 | 11.9 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.947 | 0.704 | 0.136 | 0.049 | 0.033 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 12.9 | 9.86 | 23.5 | 21.7 | 11.9 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.41 | 1.07 | 1.16 | 4.01 | 1.32 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.845 | 1.35 | 1.16 | 8.52 | 3.77 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 12 | 8.52 | 22.3 | 13.2 | 8.15 |
| Total Liabilities & Shareholders' Equity | 12.9 | 9.86 | 23.5 | 21.7 | 11.9 |
| Total Common Shares Outstanding |